20 May, 2017
On last trading day, Carrizo Oil & Gas, Inc. The company had Year Ago Sales of 3.85 Billion.
Colgate-Palmolive Company shares rose $2.47 (+3.45%) in premarket trading Wednesday. It has by 0.00% the S&P500. The firm owned 3,794 shares of the company's stock after selling 355 shares during the period. CVV's SI was 334,700 shares in May as released by FINRA.
Checking in on some valuation rankings, Oenon Holdings, Inc. Traders acquired 24,552 call options on the stock. About 2,800 shares traded. CVD Equipment Corporation (NASDAQ:CVV) has risen 6.00% since April 19, 2017 and is uptrending. COOK IAN M had sold 25,909 shares worth $1.90M on Tuesday, February 21.
In recent action, Colgate-Palmolive Company (CL) has made a move of +1.02% over the past month, which has come on Strong relative transaction volume.
In other news, insider Patricia Verduin sold 3,833 shares of the stock in a transaction that occurred on Monday, April 17th. Also, SVP John J. Huston sold 14,000 shares of the business's stock in a transaction that occurred on Wednesday, May 10th.
This company has been competing with others in the Consumer Goods space and offers its own combination of interesting factors Colgate-Palmolive Company (CL) now trades with a market capitalization of $65.64 Billion. Another trade for 7,293 shares valued at $533,556 was sold by Marsili Daniel B.
Colgate-Palmolive Company (CL) surprised the stock market in its last reported earnings when it earned $0.67 a piece versus the consensus-estimated $0.66. The firm's quarterly revenue was up.0% compared to the same quarter past year. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.01. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the company. Therefore 14% are positive. Jefferies Group LLC started coverage on shares of Colgate-Palmolive Company in a research report on Tuesday, April 18th. The firm has "Overweight" rating given on Wednesday, January 6 by Atlantic Securities. The stock's price is floating in a range of $44.17 and $44.52 whereas, it's 52-week High Price is $46.99 with respect to its 52-week Low Price of $37.62. The company was maintained on Friday, October 28 by UBS. JP Morgan analysts stated on 21/03/2017 that they launched coverage on this stock with Neutral rating. The company was downgraded on Monday, January 30 by Citigroup. The ex-dividend date is Wednesday, April 19th.
Colgate-Palmolive Company (NYSE:CL) opened at 73.93 on Friday.
Investors sentiment decreased to 0.86 in 2016 Q4. Its down 0.75, from 2.75 in 2016Q3. It fall, as 53 investors sold CL shares while 472 reduced holdings. Deutsche Fincl Bank Ag holds 0% or 3,268 shares. Dumont Blake Inv Advsrs Limited has 0.1% invested in Colgate-Palmolive Company (NYSE:CL). Fjarde Ap reported 155,720 shares. The Market Capitalization of the company stands at 67.2 Billion. Dowling & Yahnke LLC raised its stake in Colgate-Palmolive Company by 0.6% in the third quarter. Mcf Ltd accumulated 0.01% or 630 shares. Its down 73.76% from 34,300 shares previously. 8,596 were accumulated by Sigma Planning. Sumitomo Life Insur invested in 0.29% or 31,008 shares. Boothbay Fund Management Llc, a New York-based fund reported 12,300 shares. Stock institutional ownership is 79.10% while insider ownership includes 0.30%. Wade G W And invested in 147,524 shares or 2.81% of the stock. Creative Planning holds 1 shares or 0% of its portfolio. Wealthtrust holds 4 shares. Birch Hill Limited Liability Com accumulated 2.08% or 197,967 shares. Dimensional Fund Limited Partnership, a Texas-based fund reported 1.66M shares. Spinnaker Trust has 7,481 shares for 0.07% of their portfolio. Cap Advisers Lc has 1.64 million shares for 1.85% of their portfolio. The mean target of $75.50 should be compared with the price when the stock was languishing around $63.09 a share.
What Analysts Say About Kite Pharma, Inc. During the same quarter a year ago, the company earned $0.63 earnings per share.
These analysts also forecasted Growth Estimates for the Current Quarter for CL to be 2.9%.
Analyst's Analysis on Carrizo Oil & Gas, Inc. The rating was downgraded by RBC Capital Markets to "Sector Perform" on Monday, January 4. The shares were sold at an average price of $71.53, for a total value of $1,001,420.00. The company was upgraded on Thursday, September 17 by S&P Research.
Stock has got outperform rating from 9 analysts of Thomson Reuters whereas 11 analysts given hold rating to the stock.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.